CALYPTE BIOMEDICAL CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 26 rows, 26 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2012-12-28: Reporting owner Al Yousefi Tareq; Form 4; Security Nonqualified Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2012-12-28: Reporting owner Edilashvili Kartlos; Form 4; Security Incentive Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2012-12-28: Reporting owner KARAS ADEL; Form 4; Security Incentive Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2008-06-26: Reporting owner TAYLOR DONALD N; Form 3; Security Non-qualified Stock option; Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2012-12-28 | Al Yousefi Tareq Director | 4 | Nonqualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +500,000 500,000 owned after | $0.03 exercise price | 2013-01-02 | |
| 2012-12-28 | Edilashvili Kartlos Director, Officer (CFO and Secretary) | 4 | Incentive Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,000,000 2,000,000 owned after | $0.03 exercise price | 2013-01-02 | |
| 2012-12-28 | KARAS ADEL Director, Officer (President and CEO) | 4 | Incentive Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000,000 8,000,000 owned after | $0.03 exercise price | 2013-01-02 | |
| 2008-06-26 holding as of filing | TAYLOR DONALD N Officer (President and CEO) | 3 | Non-qualified Stock option Derivative · Direct | Holding | $0.05 exercise price | 2008-06-26 | ||
| 2008-04-01 | DOTSON JERROLD DUANE Officer (VP - Finance &Administration) | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,750,000 2,805,633 owned after | $0.07 exercise price | 2008-04-03 | |
| 2008-04-01 | DOTSON JERROLD DUANE Officer (VP - Finance &Administration) | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,000,000 3,805,633 owned after | $0.07 exercise price | 2008-04-03 | |
| 2008-04-01 | GALE ROGER I Director, Officer (President and CEO) | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000,000 18,134,136 owned after | $0.07 exercise price | 2008-04-03 | |
| 2008-04-01 | MINK RONALD WILLIAM Officer (Chief Science Officer) | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,750,000 3,316,667 owned after | $0.07 exercise price | 2008-04-03 | |
| 2008-04-01 | MINK RONALD WILLIAM Officer (Chief Science Officer) | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +500,000 3,816,667 owned after | $0.07 exercise price | 2008-04-03 | |
| 2007-11-28 | SOULIMOV MAXIM A Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,000,000 1,700,000 owned after | $0.11 exercise price | 2007-12-04 | |
| 2007-11-28 | SOULIMOV MAXIM A Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 1,900,000 owned after | $0.11 exercise price | 2007-12-04 | |
| 2007-11-28 | KARAS ADEL Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,000,000 1,500,000 owned after | $0.11 exercise price | 2007-12-03 | |
| 2007-11-28 | KREVANS JULIUS R Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,000,000 1,807,834 owned after | $0.11 exercise price | 2007-11-30 | |
| 2007-11-28 | KREVANS JULIUS R Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +202,834 2,010,668 owned after | $0.11 exercise price | 2007-11-30 | |
| 2007-11-28 | FREIMAN PAUL E Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,000,000 1,809,901 owned after | $0.11 exercise price | 2007-11-30 | |
| 2007-11-28 | FREIMAN PAUL E Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +202,834 2,012,735 owned after | $0.11 exercise price | 2007-11-30 | |
| 2007-11-28 | DIPIETRO JOHN J Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,000,000 1,807,734 owned after | $0.11 exercise price | 2007-11-30 | |
| 2007-11-28 | DIPIETRO JOHN J Director | 4 | Non-Qualified Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +202,734 2,010,468 owned after | $0.11 exercise price | 2007-11-30 | |
| 2007-08-08 holding as of filing | MINK RONALD WILLIAM Officer (Chief Science Officer) | 3 | Stock option Derivative · Direct | Holding | $0.32 exercise price | 2007-08-08 | ||
| 2007-08-08 holding as of filing | MINK RONALD WILLIAM Officer (Chief Science Officer) | 3 | Stock option Derivative · Direct | Holding | $0.32 exercise price | 2007-08-08 | ||
| 2007-08-08 holding as of filing | MINK RONALD WILLIAM Officer (Chief Science Officer) | 3 | Stock option Derivative · Direct | Holding | $0.59 exercise price | 2007-08-08 | ||
| 2007-08-08 holding as of filing | MINK RONALD WILLIAM Officer (Chief Science Officer) | 3 | Stock option Derivative · Direct | Holding | $0.38 exercise price | 2007-08-08 | ||
| 2007-08-08 holding as of filing | CLARK JOHN DANIEL Officer (VP-Sales and Marketing) | 3 | Stock Option Derivative · Direct | Holding | $0.14 exercise price | 2007-08-08 | ||
| 2007-02-06 holding as of filing | DOTSON JERROLD DUANE Officer (VP Fin & Admin, Corp Secretary) | 3 | Stock option Derivative · Direct | Holding | $0.32 exercise price | 2007-02-06 | ||
| 2007-02-06 holding as of filing | DOTSON JERROLD DUANE Officer (VP Fin & Admin, Corp Secretary) | 3 | Stock option Derivative · Direct | Holding | $0.32 exercise price | 2007-02-06 | ||
| 2007-02-06 holding as of filing | DOTSON JERROLD DUANE Officer (VP Fin & Admin, Corp Secretary) | 3 | Stock option Derivative · Direct | Holding | $0.59 exercise price | 2007-02-06 |